|
|
||||||||
The Journal of Immunology, Vol 131, Issue 1 158-164, Copyright © 1983 by American Association of Immunologists
ARTICLES |
H Kaneoka, G Perez-Rojas, T Sasasuki, CJ Benike and EG Engleman
Anti-Leu-4 is a murine monoclonal antibody that defines a molecule of 20,000 to 25,000 daltons present on all mature T lymphocytes in man. When cultured in the presence of 10 to 1000 ng/ml anti-Leu-4, the T cells of most individuals proliferate with peak responses on the third day of culture. T cells of both helper and suppressor lineages proliferate, but only in the presence of monocytes. Approximately 40% of individuals tested responded weakly or not at all to anti-Leu-4, despite normal responses to other stimuli. The variation in responsiveness between individuals could not be explained by differences in Leu-4 antigen density on the surface of T cells, differences in the rate of Leu-4 antigen modulation, or structural differences in the Leu-4 molecule as defined by the method of two- dimensional polyacrylamide gel electrophoresis. In the presence of monocytes from high responders, the T cells from low responders proliferated vigorously to anti-Leu-4, whereas monocytes from low responders failed to support proliferation by high responder T cells. On the other hand, low responder monocytes did not prevent T cells from proliferating in the presence of high responder monocytes. These results suggest that the failure of some individuals to respond to anti- Leu-4 is due to the absence or dysfunction of an essential monocyte population.
This article has been cited by other articles:
![]() |
L. C. L. Lim, M. N. Fiordalisi, J. L. Mantell, J. L. Schmitz, and J. D. Folds Clin. Vaccine Immunol., May 1, 1998; 5(3): 392 - 398. [Abstract] |
||||
![]() |
J Banchereau, P de Paoli, A Valle, E Garcia, and F Rousset Long-term human B cell lines dependent on interleukin-4 and antibody to CD40 Science, January 4, 1991; 251(4989): 70 - 72. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |